3-Isoquinolinecarboxylicacid,2-[(2S)-2-[[(1S)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-,hydrochloride (1:1), (3S)- cas no:82586-52-5
Synonyms: (3S)-2-((2S)-N-((1S)-1-Carboxy-3-phenylpropyl)alanyl)-1,2,3,4-tetrahydro-6,7-dimethoxy-3-isoquinolinecarboxylic acid, 2-ethyl ester, monohydrochloride;Moexipril HCl;UNII-Q1UMG3UH45;RS 10085-197;SPM 925;Univasc;CI 925;
Name3-Isoquinolinecarboxylicacid,2-[(2S)-2-[[(1S)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-,hydrochloride (1:1), (3S)-
CAS82586-52-5
Synonyms(3S)-2-((2S)-N-((1S)-1-Carboxy-3-phenylpropyl)alanyl)-1,2,3,4-tetrahydro-6,7-dimethoxy-3-isoquinolinecarboxylic acid, 2-ethyl ester, monohydrochloride;Moexipril HCl;UNII-Q1UMG3UH45;RS 10085-197;SPM 925;Univasc;CI 925;
Molecular FormulaC27H34N2O7.ClH
Molecular Weight535.029
Appearancea fine white to off-white powder
storage temp2-8°C
Hazard N:Dangerous for the environment
Risk R50
Safety
Moderately toxic by ingestion and intravenous routes. When heated to decomposition it emits toxic vapors of NOx, HCl, and Cl?.
Hazard Codes:
N
Risk Statements:
R50:Very toxic to aquatic organisms.
Safety Statements:
S60:This material and its container must be disposed of as hazardous waste.?
RIDADR: UN 3077 9/PG 3
RTECS: NW7174500
Organism |
Test Type |
Route |
Reported Dose (Normalized Dose) |
Effect |
Source |
dog |
LD50 |
oral |
> 900mg/kg (900mg/kg) |
? |
Arzneimittel-Forschung. Drug Research. Vol. 47, Pg. 132, 1997. |
mouse |
LD50 |
intravenous |
830mg/kg (830mg/kg) |
behavioral: changes in motor activity (specific assay) behavioral: ataxia lungs, thorax, or respiration: dyspnea |
Arzneimittel-Forschung. Drug Research. Vol. 47, Pg. 132, 1997. |
mouse |
LD50 |
oral |
2209mg/kg (2209mg/kg) |
behavioral: somnolence (general depressed activity) |
Arzneimittel-Forschung. Drug Research. Vol. 47, Pg. 132, 1997. |
rat |
LD50 |
intravenous |
461mg/kg (461mg/kg) |
behavioral: changes in motor activity (specific assay) behavioral: ataxia lungs, thorax, or respiration: dyspnea |
Arzneimittel-Forschung. Drug Research. Vol. 47, Pg. 132, 1997. |
rat |
LD50 |
oral |
4015mg/kg (4015mg/kg) |
behavioral: somnolence (general depressed activity) gastrointestinal: "hypermotility, diarrhea" skin and appendages (skin): hair: other |
Arzneimittel-Forschung. Drug Research. Vol. 47, Pg. 132, 1997. |